José Pablo Berros

BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors

María González‐Cao, Clara Mayo‐de‐las‐Casas, Miguel Ángel Molina‐Vila et al. · Melanoma Research · 2015 · 78 citations · Full text

Immunology, Pathology, Nucleic Acid Biomarkers +17

Prognostic Factors in Patients With Advanced Renal Cell Carcinoma

Carolina Muriel López, Emilio Esteban, José Pablo Berros et al. · Clinical Genitourinary Cancer · 2012 · 34 citations · Full text

Prognostic Factors, Urology, Genitourinary Cancer +2

Prolonged Clinical Benefit of Everolimus Therapy in the Management of High-Grade Pancreatic Neuroendocrine Carcinoma

Paula Jiménez Fonseca, E. Uriol, José A. Galván et al. · Case Reports in Oncology · 2013 · 23 citations · Full text

Prolonged Clinical Benefit, Everolimus Therapy, Surgical Oncology +14

Predictive factors for response to treatment in patients with advanced renal cell carcinoma

Carolina Muriel López, Emilio Esteban, Aurora Astudillo et al. · Investigational New Drugs · 2012 · 21 citations

Urology, Genitourinary Cancer, Medicine +4

Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study

Xavier García del Muro, Joan Maurel, Javier Martínez‐Trufero et al. · Investigational New Drugs · 2018 · 15 citations

Spanish Group, Vegfr Inhibitor Sorafenib, Surgical Oncology +8